NR3C2 and hydrops fetalis: For example, patients with HF with reduced ejection fraction should be assessed on an individual basis to potentially commence on the four pillars of HF treatment (RAAS inhibition, beta blockade, mineralocorticoid receptor antagonism, and sodium-glucose co-transporter inhibition), alongside diuretics and anaemia control.